Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Testing effectiveness (Phase 2)Study completedNCT03081702What this trial is testingThe Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian CancerWho this might be right forPlatinum-resistant Epithelial Ovarian Cancer University Health Network, Toronto 13
Testing effectiveness (Phase 2)Study completedNCT02001272What this trial is testingEWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian CancerWho this might be right forOvarian Cancer Hospices Civils de Lyon 120
Testing effectiveness (Phase 2)Looking for participantsNCT07488676What this trial is testingASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsWho this might be right forGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 150
Not applicableActive Not RecruitingNCT07678008What this trial is testingPrognostic Value of KELIM Score and Inflammatory Markers in Ovarian CancerWho this might be right forAdvanced Ovarian Cancer (Stage III or IV) After Neoadjuvant ChemotherapyHigh-grade Serous Ovarian Carcinoma Aya Ahmed Nasser 80
Testing effectiveness (Phase 2)Study completedNCT00070096What this trial is testingIxabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell TumorsWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01078662What this trial is testingOpen Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation PatsWho this might be right forOvarianBreastProstate+2 more AstraZeneca 298
Not applicableNot Yet RecruitingNCT07267780What this trial is testingContribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.Who this might be right forOvarian CarcinomaCervical CarcinomaEndometrial Carcinoma+3 more National Cancer Institute, Naples 130
Testing effectiveness (Phase 2)Study completedNCT00193297What this trial is testingTopotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal CarcinomaWho this might be right forOvary Cancer SCRI Development Innovations, LLC 50
Testing effectiveness (Phase 2)Study completedNCT02611024What this trial is testingPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsWho this might be right forAdvanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more PharmaMar 316
Not applicableStudy completedNCT01595204What this trial is testingValidation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer PatientsWho this might be right forCancer of Ovary Catholic University of the Sacred Heart 163
Not applicableTemporarily Not AvailableNCT03842865What this trial is testingExpanded Access of Vigil in Solid TumorsWho this might be right forSolid TumorEwing SarcomaEwing's Tumor Metastatic+5 more Gradalis, Inc.
Testing effectiveness (Phase 2)Study completedNCT03161132What this trial is testingResistant Ovarian Cancer, Olaparib and Liposomal DoxorubicinWho this might be right forAdvanced Ovarian Cancer Grupo Español de Investigación en Cáncer de Ovario 32
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 1,109
Testing effectiveness (Phase 2)Study completedNCT00390234What this trial is testingZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaWho this might be right forFallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more National Cancer Institute (NCI) 63
Early research (Phase 1)UnknownNCT04029909What this trial is testingA Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerWho this might be right forOvarian Epithelial CancerFallopian Tube CancerPrimary Peritoneal Cancer Lee's Pharmaceutical Limited 12
Not applicableStudy completedNCT01863693What this trial is testingAn Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)Who this might be right forOvarian Cancer Hoffmann-La Roche 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06334432What this trial is testingSafety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorHER2-negative Breast CancerMetastatic Castration-resistant Prostate Cancer (mCRPC)+2 more Nuvation Bio Inc. 466
Testing effectiveness (Phase 2)Ended earlyNCT03323398What this trial is testingDose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced MalignanciesWho this might be right forRelapsed/Refractory Solid Tumor Malignancies or LymphomaOvarian Cancer ModernaTX, Inc. 79
Testing effectiveness (Phase 2)Looking for participantsNCT05824975What this trial is testingEvaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more GI Innovation, Inc. 358